184 related articles for article (PubMed ID: 1325279)
1. Neuroblastoma. Effect of genetic factors on prognosis and treatment.
Brodeur GM; Azar C; Brother M; Hiemstra J; Kaufman B; Marshall H; Moley J; Nakagawara A; Saylors R; Scavarda N
Cancer; 1992 Sep; 70(6 Suppl):1685-94. PubMed ID: 1325279
[TBL] [Abstract][Full Text] [Related]
2. Molecular basis of clinical heterogeneity in neuroblastoma.
Brodeur GM; Nakagawara A
Am J Pediatr Hematol Oncol; 1992 May; 14(2):111-6. PubMed ID: 1356315
[TBL] [Abstract][Full Text] [Related]
3. Neuroblastoma--clinical applications of molecular parameters.
Brodeur GM
Brain Pathol; 1990 Sep; 1(1):47-54. PubMed ID: 1669693
[TBL] [Abstract][Full Text] [Related]
4. Neuroblastoma: clinical significance of genetic abnormalities.
Brodeur GM
Cancer Surv; 1990; 9(4):673-88. PubMed ID: 2101728
[TBL] [Abstract][Full Text] [Related]
5. Molecular basis for heterogeneity in human neuroblastomas.
Brodeur GM
Eur J Cancer; 1995; 31A(4):505-10. PubMed ID: 7576954
[TBL] [Abstract][Full Text] [Related]
6. Cytogenetic findings and prognosis in neuroblastoma with emphasis on marker chromosome 1.
Hayashi Y; Kanda N; Inaba T; Hanada R; Nagahara N; Muchi H; Yamamoto K
Cancer; 1989 Jan; 63(1):126-32. PubMed ID: 2910410
[TBL] [Abstract][Full Text] [Related]
7. Clinical significance of genetic rearrangements in human neuroblastomas.
Brodeur GM
Clin Chem; 1989 Jul; 35(7 Suppl):B38-42. PubMed ID: 2568197
[TBL] [Abstract][Full Text] [Related]
8. Loss of heterozygosity for the short arm of chromosome 1 in human neuroblastomas: correlation with N-myc amplification.
Fong CT; Dracopoli NC; White PS; Merrill PT; Griffith RC; Housman DE; Brodeur GM
Proc Natl Acad Sci U S A; 1989 May; 86(10):3753-7. PubMed ID: 2566996
[TBL] [Abstract][Full Text] [Related]
9. Loss of heterozygosity for chromosomes 1 or 14 defines subsets of advanced neuroblastomas.
Fong CT; White PS; Peterson K; Sapienza C; Cavenee WK; Kern SE; Vogelstein B; Cantor AB; Look AT; Brodeur GM
Cancer Res; 1992 Apr; 52(7):1780-5. PubMed ID: 1551108
[TBL] [Abstract][Full Text] [Related]
10. Deletion of chromosome 1p loci and microsatellite instability in neuroblastomas analyzed with short-tandem repeat polymorphisms.
Martinsson T; Sjöberg RM; Hedborg F; Kogner P
Cancer Res; 1995 Dec; 55(23):5681-6. PubMed ID: 7585654
[TBL] [Abstract][Full Text] [Related]
11. Similar chromosomal patterns and lack of N-myc gene amplification in localized and IV-S stage neuroblastomas in infants.
Hayashi Y; Inaba T; Hanada R; Yamada M; Nakagome Y; Yamamoto K
Med Pediatr Oncol; 1989; 17(2):111-5. PubMed ID: 2704332
[TBL] [Abstract][Full Text] [Related]
12. Current urinary mass screening for catecholamine metabolites at 6 months of age may be detecting only a small portion of high-risk neuroblastomas: a chromosome and N-myc amplification study.
Kaneko Y; Kanda N; Maseki N; Nakachi K; Takeda T; Okabe I; Sakurai M
J Clin Oncol; 1990 Dec; 8(12):2005-13. PubMed ID: 2230892
[TBL] [Abstract][Full Text] [Related]
13. Clinical relevance of tumor cell ploidy and N-myc gene amplification in childhood neuroblastoma: a Pediatric Oncology Group study.
Look AT; Hayes FA; Shuster JJ; Douglass EC; Castleberry RP; Bowman LC; Smith EI; Brodeur GM
J Clin Oncol; 1991 Apr; 9(4):581-91. PubMed ID: 2066755
[TBL] [Abstract][Full Text] [Related]
14. Significance of chromosome 1p loss of heterozygosity in neuroblastoma.
Maris JM; White PS; Beltinger CP; Sulman EP; Castleberry RP; Shuster JJ; Look AT; Brodeur GM
Cancer Res; 1995 Oct; 55(20):4664-9. PubMed ID: 7553646
[TBL] [Abstract][Full Text] [Related]
15. There may be two tumor suppressor genes on chromosome arm 1p closely associated with biologically distinct subtypes of neuroblastoma.
Takeda O; Homma C; Maseki N; Sakurai M; Kanda N; Schwab M; Nakamura Y; Kaneko Y
Genes Chromosomes Cancer; 1994 May; 10(1):30-9. PubMed ID: 7519871
[TBL] [Abstract][Full Text] [Related]
16. Loss of heterozygosity at 1p36 independently predicts for disease progression but not decreased overall survival probability in neuroblastoma patients: a Children's Cancer Group study.
Maris JM; Weiss MJ; Guo C; Gerbing RB; Stram DO; White PS; Hogarty MD; Sulman EP; Thompson PM; Lukens JN; Matthay KK; Seeger RC; Brodeur GM
J Clin Oncol; 2000 May; 18(9):1888-99. PubMed ID: 10784629
[TBL] [Abstract][Full Text] [Related]
17. Cytogenetic features of human neuroblastomas and cell lines.
Brodeur GM; Green AA; Hayes FA; Williams KJ; Williams DL; Tsiatis AA
Cancer Res; 1981 Nov; 41(11 Pt 1):4678-86. PubMed ID: 6171342
[TBL] [Abstract][Full Text] [Related]
18. Combined analysis of DNA ploidy index and N-myc genomic content in neuroblastoma.
Bourhis J; De Vathaire F; Wilson GD; Hartmann O; Terrier-Lacombe MJ; Boccon-Gibod L; McNally NJ; Lemerle J; Riou G; Bénard J
Cancer Res; 1991 Jan; 51(1):33-6. PubMed ID: 1988094
[TBL] [Abstract][Full Text] [Related]
19. Deletion map of chromosome 9 and p16 (CDKN2A) gene alterations in neuroblastoma.
Takita J; Hayashi Y; Kohno T; Yamaguchi N; Hanada R; Yamamoto K; Yokota J
Cancer Res; 1997 Mar; 57(5):907-12. PubMed ID: 9041193
[TBL] [Abstract][Full Text] [Related]
20. Loss of the putative tumor suppressor-gene locus 1p36 as investigated by a PCR-assay and N-myc amplification in 48 neuroblastomas: results of the German Neuroblastoma Study Group.
Christiansen H; Delattre O; Fuchs S; Theobald M; Christiansen NM; Berthold F; Lampert F
Prog Clin Biol Res; 1994; 385():19-25. PubMed ID: 7972212
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
